81 related articles for article (PubMed ID: 1881024)
21. [Long-term efficacy of radiotherapy on children with nasopharyngeal carcinoma].
Cao KJ; Li Y; Huang PY; Xie GF; Huang TB; Hong MH
Ai Zheng; 2004 Nov; 23(11):1322-4. PubMed ID: 15522182
[TBL] [Abstract][Full Text] [Related]
22. [Significance of cell-free Epstein-Barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma].
Cao SM; Min HQ; Gao JS; Hong MH; Xiao XB; Zhang CQ; Liu XD; Zhang AL; Guo X
Ai Zheng; 2003 Mar; 22(3):302-6. PubMed ID: 12654192
[TBL] [Abstract][Full Text] [Related]
23. Prognostic features and treatment outcome in patients with nasopharyngeal carcinoma: an experience of 20 years.
Tombolini V; De Sanctis V; Donato V; Osti MF; Raffetto N; Santarelli M; Domenico V; De Nicolo M; Enrici RM
Anticancer Res; 2001; 21(2B):1413-8. PubMed ID: 11396224
[TBL] [Abstract][Full Text] [Related]
24. [Symptoms and prognosis of nasopharyngeal carcinoma].
Yi JL; Gao L; Huang XD; Li SY; Luo JW; Xu GZ; Xiao JP; Cai WM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):315-7. PubMed ID: 16900622
[TBL] [Abstract][Full Text] [Related]
25. Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects.
Orbach D; Brisse H; Helfre S; Klijanienko J; Bours D; Mosseri V; Rodriguez J
Pediatr Blood Cancer; 2008 Apr; 50(4):849-53. PubMed ID: 17973328
[TBL] [Abstract][Full Text] [Related]
26. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
Chua DT; Wei WI; Sham JS; Cheng AC; Au G
Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
[TBL] [Abstract][Full Text] [Related]
27. [Molecular genetic progression on nasopharyngeal carcinoma].
Shao JY; Zeng WF; Zeng YX
Ai Zheng; 2002 Jan; 21(1):1-10. PubMed ID: 12500388
[TBL] [Abstract][Full Text] [Related]
28. Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy.
Chang JT; Lin CY; Chen TM; Kang CJ; Ng SH; Chen IH; Wang HM; Cheng AJ; Liao CT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1354-60. PubMed ID: 16297716
[TBL] [Abstract][Full Text] [Related]
29. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
30. Nasopharyngeal carcinoma: the role of magnetic resonance imaging in diagnosis, staging, treatment, and follow-up.
Glastonbury CM
Top Magn Reson Imaging; 2007 Aug; 18(4):225-35. PubMed ID: 17893588
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
Liu MT; Yeh CY
Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma.
Yau TK; Sze WM; Lee WM; Yeung MW; Leung KC; Hung WM; Chan WI
Head Neck; 2004 Dec; 26(12):1024-30. PubMed ID: 15390194
[TBL] [Abstract][Full Text] [Related]
33. [Impact of dose boost in skull base on recurrence of stage T4 nasopharyngeal carcinoma].
Xie GF; Cao KJ; Li Y; Huang PY
Ai Zheng; 2005 Oct; 24(10):1246-8. PubMed ID: 16219141
[TBL] [Abstract][Full Text] [Related]
34. [Application of interstitial brachytherapy via parapharynx involvement transnasal approach to enhance dose in radiotherapy for nasopharyngeal carcinoma].
Chen MY; Cao XP; Sun R; Hua YJ; Li AJ; Liu YY; Ouyang Y; Guo L; Chen QY; Hong MH
Ai Zheng; 2007 May; 26(5):513-8. PubMed ID: 17672943
[TBL] [Abstract][Full Text] [Related]
35. Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten-year experience of a single institution.
Yi JL; Gao L; Huang XD; Li SY; Luo JW; Cai WM; Xiao JP; Xu GZ
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):161-8. PubMed ID: 16542792
[TBL] [Abstract][Full Text] [Related]
36. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.
Leung SF; Chan AT; Zee B; Ma B; Chan LY; Johnson PJ; Lo YM
Cancer; 2003 Jul; 98(2):288-91. PubMed ID: 12872347
[TBL] [Abstract][Full Text] [Related]
37. Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast Asia.
Lu H; Peng L; Yuan X; Hao Y; Lu Z; Chen J; Cheng J; Deng S; Gu J; Pang Q; Qin J
Cancer Treat Rev; 2009 Jun; 35(4):345-53. PubMed ID: 19211192
[TBL] [Abstract][Full Text] [Related]
38. Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center.
Geara FB; Nasr E; Tucker SL; Brihi E; Zaytoun G; Hadi U; Salem Z; El Saghir N; Issa P; Shamseddine A
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1408-15. PubMed ID: 15817344
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of parapharyngeal space venous plexus and marrow involvement: potential landmarks of dissemination for stage I-III nasopharyngeal carcinoma.
Cheng SH; Tsai SY; Yen KL; Jian JJ; Feng AC; Chan KY; Hong CF; Chu NM; Lin YC; Lin CY; Tan TD; Hsieh CY; Chong V; Huang AT
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):456-65. PubMed ID: 15667967
[TBL] [Abstract][Full Text] [Related]
40. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]